ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Berlin, BE, DEU:

DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Berlin, Germany and 226 other locations

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 145 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Active, not recruiting
Advanced Breast Cancer
Drug: ARV-471
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Berlin, Germany and 317 other locations

This is a single-arm, open-label phase IV study of patients with advanced HR+/HER2- breast cancer who are treated first line with r...

Enrolling
Breast Cancer
Breast Cancer Female
Drug: Ribociclib

Phase 4

Institute for Women's Health (IFG)

Berlin, Germany and 51 other locations

(BMs), with previously-treated advanced/metastatic HER2-positive breast cancer whose disease has progressed on prior anti-HER2-base...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab Deruxtecan

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 80 other locations

The treatment of patients with HER2 positive early breast cancer has continuously improved over the last decades. Up to now both, t ...

Enrolling
Breast Cancer
Breast Cancer Female
Drug: Chemotherapy
Drug: Pertuzumab

Phase 4

Institute for Women's Health (IFG)

Berlin, Germany and 10 other locations

PREcoopERA is a randomized (2:2:1), multicenter, open-label, three-arm (A, B, C), Window-of-Opportunity (WOO) trial to evaluate the activity and safe...

Enrolling
Breast Cancer
Drug: Triptorelin
Drug: Anastrozole

Phase 2

ETOP IBCSG Partners Foundation

Berlin, Germany and 43 other locations

endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast...

Enrolling
Breast Cancer
Drug: Elacestrant
Drug: Tamoxifen

Phase 3

Stemline Therapeutics
Stemline Therapeutics

Brandenburg, Fuerstenwalde /Spree, Germany and 302 other locations

Phase III, prospective, multi-center, randomized, open label, parallel group, study in patients with HER2-negative breast cancer wi...

Active, not recruiting
Triple Negative Breast Cancer
HER2-negative Breast Cancer
Drug: Sacituzumab govitecan
Drug: Cisplatin

Phase 3

GBG Forschungs GmbH

Berlin, Germany and 162 other locations

patients with metastatic hormone receptor positive HER2 negative breast cancer in the first line setting.Side effect monitoring and...

Enrolling
HER2-negative Metastatic Breast Cancer
Hormone Receptor-positive Metastatic Breast Cancer
Drug: Abemaciclib + Aromatase Inhibitor
Drug: Abemaciclib + Fulvestrant

Phase 4

Prof. Wolfgang Janni

Berlin, Germany and 53 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems